Product Information
PACERONE 200 MG TABLET is a brand (anda) product labeled by Upsher-Smith Laboratories LLC, priced at $0.1249 per EA under NDC 00245014701. Its NADAC has been published 346 times since Nov 28, 2013.
FDA first approved this application on Apr 30, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245014701
Classification
Brand (ANDA)
Dosage Form
TABLET
Route
ORAL
Effective Date
11/19/2025
Active Ingredients
AMIODARONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075135FDA Approved
4/30/1998
TE Code
AB
On Market Since
11/15/2010
Pharmacological Classes
Price Statistics
The NADAC for PACERONE 200 MG TABLET has been published 346 times since Nov 28, 2013, and over the history we have for it it has declined 9.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1249 per EA |
|---|---|
| All-time high | $0.1771 (Mar 16, 2022) |
| All-time low | $0.1126 (Mar 23, 2022) |
| 52-week high | $0.1489 |
| 52-week low | $0.1249 |
| Median price | $0.1427 |
| Average price | $0.1420 |
| Largest weekly change | -36.4% (Mar 23, 2022) |
| Weeks tracked | 346 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PACERONE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PACERONE 200 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.1249 per EA (NDC 00245014701), effective Aug 19, 2026.
How has the price of PACERONE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for PACERONE 200 MG TABLET has declined 9.1%. It has been tracked across 346 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PACERONE 200 MG TABLET?
Since Nov 28, 2013, the NADAC for PACERONE 200 MG TABLET has ranged from a low of $0.1126 (Mar 23, 2022) to a high of $0.1771 (Mar 16, 2022), with a median of $0.1427 per EA.
Are there cheaper alternatives to PACERONE 200 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMIODARONE HCL 200 MG TABLET, is $0.1206 per EA — about 3% below PACERONE 200 MG TABLET.
Who manufactures PACERONE 200 MG TABLET?
PACERONE 200 MG TABLET (NDC 00245014701) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand (anda) product.